Publications

MVision AI’s Dose+ Receives FDA 510(k) Clearance for Clinical Use in the United States
Helsinki, September 2025 – MVision AI is proud to announce that Dose+, its AI-powered solution for dose prediction and personalised radiotherapy treatment planning, has received…
AI in Prostate Cancer Radiotherapy Planning
Across much of the world, men are living into older age in greater numbers than ever before. With this increase in years comes a different…
MVision AI’s Dose+ Receives Market Approval in Australia
Helsinki, August 2025 — MVision AI announces that Dose+ has received market approval for the Australian market from the Therapeutic Goods Administration (TGA). The product…
Multi-Institutional Study Demonstrates Time and Consistency Benefits of MVision Contour+ for Head and Neck Radiotherapy
MVision Contour+ improves consistency and saves time, according to HARMONY, a multi-institutional international study. The research was conducted in seven clinics from four countries and…
Case Study: Evaluating AI Dose Prediction Across Standard and Complex Prostate Cases at NCCC, Newcastle
Overview For many radiotherapy departments, the integration of new technologies must complement rather than replace established planning processes. The Northern Centre for Cancer Care (NCCC)…
Case Study: SLRON’s Integration of MVision AI in Radiotherapy Planning and Clinical Training
Overview St. Luke’s Radiation Oncology Network (SLRON) is Ireland’s largest radiotherapy provider and one of the largest centres in Europe. It treats over 5,500 patients…
MVision AI’s Contour+ Receives Market Approval in Morocco
Helsinki, June 2025 — MVision AI is pleased to announce that Contour+, its AI-powered auto-contouring software for radiation therapy, has received market approval for clinical…
MVision AI’s Contour+ Approved for Clinical Use in Singapore
Helsinki, May 2025 — MVision AI announces that Contour+, its AI-based auto-contouring software for radiation therapy, has received market approval for clinical use in Singapore.…
MVision AI’s Contour+ Receives Market Clearance in the United Arab Emirates
HELSINKI, Finland – April 2025 — Contour+, MVision AI’s AI-powered auto-contouring software, has received market clearance from the United Arab Emirates Ministry of Health and…
MVision AI Announces Dose+: Dose Prediction Software for AI-driven Radiation Therapy Planning
Helsinki, Finland – February 2025 – MVision AI announces the introduction of Dose+, a software medical device designed to assist radiation therapy professionals in treatment…